Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Lapeire Lore; Hendrix An; Lecoutere Evelyne; Van Bockstal Mieke; Vandesompele Jo; Maynard Dawn; Braems Geert; Van Den Broecke Rudy; Müller Cathérine; Bracke Marc; Cocquyt Véronique; Denys Hannelore; De Wever Olivier

doi:10.18632/oncotarget.17592

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Lapeire Lore, Hendrix An, Lecoutere Evelyne, Van Bockstal Mieke, Vandesompele Jo, Maynard Dawn, Braems Geert, Van Den Broecke Rudy, Müller Cathérine, Bracke Marc, Cocquyt Véronique, Denys Hannelore and De Wever Olivier _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:47239-47249. https://doi.org/10.18632/oncotarget.17592

Metrics: PDF 2317 views | HTML 3416 views | ?

Abstract

Lapeire Lore1,2, Hendrix An2,3, Lecoutere Evelyne4, Van Bockstal Mieke4, Vandesompele Jo2,5, Maynard Dawn6, Braems Geert7, Van Den Broecke Rudy7, Müller Cathérine8, Bracke Marc3, Cocquyt Véronique1, Denys Hannelore1,2 and De Wever Olivier2,3

1Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium

2Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium

3Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium

4Department of Pathology, Ghent University Hospital, Ghent, Belgium

5Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium

6Medical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, USA

7Department of Gynecology, Ghent University Hospital, Ghent, Belgium

8Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, UPS, Toulouse, France

Correspondence to:

De Wever Olivier, email: [email protected]

Keywords: adipose tissue, breast cancer, proliferation, secretome, palbociclib

Received: November 01, 2016 Accepted: April 17, 2017 Published: May 03, 2017

ABSTRACT

Adipose tissue secretes a plethora of adipokines as evidenced by characterization of subcutaneous and visceral adipose tissue secretomes. However, adipose tissue composition and secretion pattern is depot and disease dependent, influencing the adipose tissue secretome. We investigated the secretome of cancer-associated adipose tissue (CAAT) explants from breast cancer patients and explored its role in breast cancer proliferation. CAAT proteins were identified by LC-MS/MS and human protein antibody arrays and stimulated proliferation of three breast cancer cell lines. Kinomics and transcriptomics of MCF-7 breast cancer cells treated with the secretome of CAAT revealed activation of Akt-, ERK- and JNK-pathways and differential expression of activator protein 1 (AP-1) and cAMP responsive element-binding protein (CREB) target genes. The cyclin-dependent kinase (CDK)4/6-inhibitor palbociclib significantly abrogated CAAT-enhanced breast cancer cell proliferation. Our work characterizes the specific breast CAAT protein secretome and reveals its pro-proliferative potency in breast cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17592

Publication Alerts

Research Papers:

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Abstract